CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 805 enrolled
Drug / intervention
kalifilcon A +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04901897
NCT04901897N/ACompleted
CompareCT.gov

A Study to Evaluate the Product Performance of a New Silicone Hydrogel Contact Lens

Bausch & Lomb Incorporated·interventional·Posted May 26, 2021·Updated Jul 8, 2021

In Brief

A clinical study evaluating kalifilcon A, delefilcon A, and 1 other intervention for Myopia. Completed, enrolled 805 participants across 35 sites.

Detailed Summary

The objective of this study is to evaluate the product performance of kalifilcon A, compared to the Johnson \& Johnson Acuvue Oasys® 1-Day with HydraLuxe™ (senofilcon A) daily disposable contact lens and Alcon DAILIES TOTAL1® (delefilcon A) daily disposable contact lenses when worn by current soft contact lens wearers on a daily disposable wear basis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMay 26, 2021
Enrollment StartJul 31, 2019
Primary CompletionOct 9, 2019
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.1 years ago

Interventions

kalifilcon Adevice

kalifilcon A daily disposable contact lens

delefilcon Adevice

DAILIES TOTAL1® (delefilcon A) daily disposable contact lenses

senofilcon Adevice

Acuvue Oasys® 1-Day with HydraLuxe™ (senofilcon A) daily disposable contact lens